Arava and Trasylol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Arava and Trasylol together.

The phase IV clinical study analyzes what interactions people who take Arava and Trasylol have. It is created by eHealthMe based on reports of 5 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 27, 2022

5 people who take Arava and Trasylol together, and have interactions are studied.


What is Arava?

Arava has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 68,102 Arava users for its effectiveness, alternative drugs and more.

What is Trasylol?

Trasylol has active ingredients of aprotinin. eHealthMe is studying from 9,445 Trasylol users for its effectiveness, alternative drugs and more.

Number of Arava and Trasylol reports submitted per year:

Arava and Trasylol drug interactions.

Common Arava and Trasylol drug interactions by gender *:

female:

  1. Anxiety
  2. Death
  3. Emotional distress
  4. Fear
  5. Injury
  6. Pain
  7. Renal failure
  8. Renal impairment
  9. Renal injury
  10. Stress

male:

  1. Anxiety
  2. Depression
  3. Emotional distress
  4. Fear
  5. Injury
  6. Pain
  7. Renal failure
  8. Renal impairment
  9. Renal injury
  10. Stress

Common Arava and Trasylol drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anxiety
  2. Emotional distress
  3. Fear
  4. Injury
  5. Pain
  6. Renal failure
  7. Renal impairment
  8. Renal injury
  9. Stress
  10. Anhedonia

60+:

  1. Anxiety
  2. Death
  3. Stress
  4. Emotional distress
  5. Fear
  6. Injury
  7. Multi-organ failure
  8. Pain
  9. Renal failure
  10. Renal impairment

* Approximation only. Some reports may have incomplete information.

Do you take Arava and Trasylol?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Arava and Trasylol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Arava side effects:

Browse all side effects of Arava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Trasylol side effects:

Browse all side effects of Trasylol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Arava interactions:

Browse all interactions between Arava and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Trasylol interactions:

Browse all interactions between Trasylol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on leflunomide and aprotinin (the active ingredients of Arava and Trasylol, respectively), and Arava and Trasylol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Arava and Trasylol.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: